Analyst reclassifications at the investment bank Jefferies move several German stocks from the second and third rows of stock exchanges on Tuesday.
Papers from CompuGroup Medical temporarily lose 2.89 percent in XETRA trading to EUR 40.94 after being downgraded to “Hold”. On the other hand, the shares of ENCAVIS, which were recommended for purchase and then temporarily increased by 2.83 percent to EUR 14.33 via XETRA. CANCOM shares were also downgraded to “Hold”, but at times they were hardly impressed in XETRA trading at EUR 24.92 (+0.08 percent), after they had also been under pressure before the market opened.
The recommendations come from a study in which analyst Martin Comtesse reviewed his favorites in the European small and mid-cap space. Valuations of such stocks are close to historic lows, but there are signs of improvement as the third quarter begins.
He wrote about ENCAVIS that in view of the fall in the price, the market has now largely taken into account the return to a more normal electricity price level and should now focus on the fundamental opportunities.
At CANCOM, on the other hand, he misses medium-term impetus for a rising share price, even though the shares did not appear expensive. In his opinion, CompuGroup could miss its own medium-term goals in the current year.
/you/mis
FRANKFURT (dpa-AFX Broker)
Selected leverage products on CANCOM SE
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on CANCOM SE
Leverage must be between 2 and 20